Ivana Magovcevic-Liebisch's Net Worth

$1.1 Million

Estimate Recalculated Jul 3, 2024 03:50PM EST

Who is Ivana Magovcevic-Liebisch?

Ivana Magovcevic-Liebisch has an estimated net worth of $1.1 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Absci Corp, Aeglea BioTherapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, and DYAX CORP.

SEC CIK

Ivana Magovcevic-Liebisch's CIK is 0001279281

Past Insider Trading and Trends

2012 was Ivana Magovcevic-Liebisch's most active year for acquiring shares with 15 total transactions. Ivana Magovcevic-Liebisch's most active month to acquire stocks was the month of May. 2013 was Ivana Magovcevic-Liebisch's most active year for disposing of shares, totalling 17 transactions. Ivana Magovcevic-Liebisch's most active month to dispose stocks was the month of February. 2013 saw Ivana Magovcevic-Liebisch paying a total of $452,627.40 for 1,410,969 shares, this is the most they've acquired in one year. In 2013 Ivana Magovcevic-Liebisch cashed out on 1,395,343 shares for a total of $874,475.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.86

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 3
Form 4
0
0
Mar 1
Form 4
+1.96%
4K
$3.75
$15,000.00
207.69K
Nov 20
Form 4
0
0
Mar 1
Form 4
+2.52%
5K
$3.68
$18,379.00
203.69K
May 2 - May 3
Form 4
0
0
Mar 1
Form 3
0
0
No matching records found

Absci Corp (ABSI) Snapshot price: $4.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 8
Form 3
0
0
No matching records found

Aeglea BioTherapeutics, Inc. (AGLE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 22
Form 4
0
0
Jun 7
Form 4
0
0
Jun 8
Form 4
0
0
Jun 8
Form 4
0
0
Jun 7
Form 4
0
0
Mar 22
Form 3
0
0
No matching records found

APPLIED GENETIC TECHNOLOGIES CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 30
Form 4
0
0
Dec 16
Form 4
0
0
Dec 4
Form 4
0
0
Nov 15
Form 4/A
0
0
Jul 25
Form 4
0
0
Jul 25
Form 4
0
0
Feb 28
Form 4
3K
$9.63
$28,875.00
3K
Nov 16
Form 4
0
0
Nov 19
Form 4
0
0
Jul 11
Form 4
0
0
Dec 19
Form 3
0
0
No matching records found

DYAX CORP No price found

EVP; Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Mar 29
Form 4
-16.21%
-7.86K
$3.09
-$408,838.81
40.63K
Scheduled
Mar 6
Form 4
-7.65%
-4.01K
$3.24
-$13,009.00
48.48K
Feb 25
Form 4
0
0
Feb 7
Form 4
0
0
Oct 10
Form 4
0
0
Jun 20
Form 4
+950.00%
47.5K
52.5K
Feb 24
Form 4
5K
$1.50
$7,500.00
5K
Mar 16
Form 4
0
0
Feb 9
Form 4
0
$1.92
-$13,806.83
0
Jun 25
Form 4
0
$2.03
-$16,936.15
0
May 26
Form 4
-100.00%
-3.54K
$3.10
-$10,964.73
0
May 19
Form 4
0
0
Feb 10
Form 4
0
0
Feb 11
Form 4
0
0
Aug 7
Form 4
-62.91%
-6.00K
$5.00
-$30,000.00
3.54K
Scheduled
Apr 2
Form 4
0
0
Feb 13
Form 4
0
0
Jan 23
Form 4
0
0
Jul 2
Form 4
0
0
May 16
Form 4
0
0
Jul 3
Form 4
0
0
Dec 8
Form 4
0
0
Jun 28
Form 4
0
0
Jun 28
Form 4
16.41K
$2.43
$39,853.60
16.41K
May 13
Form 4
0
$8.10
-$117,949.36
0
Apr 30
Form 3
0
0
No matching records found